Evidence map›Paper›PMID 30414263›Full record

ArticleCancer medicine2018

EGFR confers radioresistance in human oropharyngeal carcinoma by activating endoplasmic reticulum stress signaling PERK-eIF2α-GRP94 and IRE1α-XBP1-GRP78.

Miao Zhang, Ning Han, Yuanjun Jiang, Jie Wang, Gaiyan Li, Xintong Lv, Guang Li, Qiao Qiao

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. NCancer gene therapy · 2025
    Article
  7. Article
  8. Article
  9. Prognostic stratification of oropharyngeal cancer patients in a betel nut chewing and low HPV area.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Miao ZhangDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.ORCID 0000-0003-2741-3916
Ning HanDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Yuanjun JiangDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Jie WangDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Gaiyan LiDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Xintong LvDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Guang LiDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Qiao QiaoDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
First Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The activation of epidermal growth factor receptor (EGFR) is associated with radioresistance in malignant tumors. Specifically, radiation can destroy endoplasmic reticulum (ER) homeostasis to induce ER stress (ERS). However, the effect of EGFR-mediated regulation of ERS signaling pathway on radiosensitivity has not yet been reported. The present study showed that silencing EGFR increased radiosensitivity of both radiosensitive and radioresistant oropharyngeal squamous cell carcinoma (OSCC) cells by inhibiting ER stress signaling (PERK-eIF2α-GRP94 and IRE1α-XBP1-GRP78). This effect was abolished by pretreatment with EGF, however. In addition, knockdown of EGFR in OSCC cells inhibited DNA double-stand break repair and autophagy while increased radiation-induced apoptosis. Conversely, activating ERS inhibited the aforementioned functions. Furthermore, EGF increased ER stress-independent ERK and AKT signaling upon irradiation of OSCC cells. Immunohistochemical analysis of 80 tissue samples from OSCC patients showed that co-expression of EGFR and PERK was associated with poor prognosis. It thus appears EGFR confers radioresistance in OSCC by activating ER stress signaling. These results suggested that the cooperative effects of radiotherapy and EGFR-targeted inhibitor therapy can be further improved by inhibiting PERK-eIF2α-GRP94 and IRE1α-GRP78 in non-response oropharyngeal carcinoma patients.

Indexed as

Endoplasmic Reticulum StressRadiation ToleranceCell Line, TumoreIF-2 KinaseEndoplasmic Reticulum Chaperone BiPEndoribonucleasesErbB ReceptorsEukaryotic Initiation Factor-2Heat-Shock ProteinsHumansMembrane GlycoproteinsOropharyngeal NeoplasmsProtein Serine-Threonine KinasesX-Box Binding Protein 1EGFR protein, humanEIF2AK3 protein, humaneIF-2 KinaseEndoplasmic Reticulum Chaperone BiPendoplasminEndoribonucleasesErbB ReceptorsERN1 protein, humanEukaryotic Initiation Factor-2Heat-Shock ProteinsHSPA5 protein, humanMembrane GlycoproteinsProtein Serine-Threonine KinasesX-Box Binding Protein 1XBP1 protein, humanEGFRERSoropharyngeal carcinomaradiationradioresistance

Identifiers

PMID30414263
PMCPMC6308109
OpenAlexW2899786103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.